SEC Form 4 · accession 0001209191-17-020779
INTEGRA LIFESCIENCES HOLDINGS CORP · IART
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Glenn Coleman
Officer — CVP, CHIEF FINANCIAL OFFICER
Period of report
Mar 13, 2017
Accepted (ET)
Mar 15, 2017 · 4:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000917520
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 13, 2017 | A | 5,266 | $0.00 | A | 47,043 | D | |
| Common Stock | Mar 14, 2017 | F | 1,793 | $43.03 | D | 45,250 | D | |
| Common Stock | Mar 14, 2017 | F | 479 | $43.03 | D | 44,771 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $43.68 | Mar 13, 2017 | A | 20,354 | A | — | Mar 13, 2025 | Common Stock | 20,354 | 20,354 | D |
Explanation of responses
- F133% of the shares of stock options will vest each of the first and second anniversaries of the grant date of 3/13/2017 and 34% of the shares of stock options will vest on the third anniversary of the grant date of 3/13/2017.